Watch Ticker

Design Therapeutics, Inc. Common Stock

Go to Design Therapeutics, Inc. Common Stock Website

$4.06

0.10 (2.53%)

Live

Previous Close

$4.06

Day Range

$3.9037 - $4.13

Previous Day Range

$3.85 - $4.125

Market Cap

$224.8 million USD

Day Vol.

77760

Previous Day Vol.

117355

Currency

USD

Primary Exchange

Nasdaq

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modify...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Design Therapeutics, Inc. - Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2024 RBC Capital Markets Healthcare Conference on Wednesday, May 15, 2024, at 11:30 a.m. ET in New York.

Related tickers: DSGN.

Read Full Article

Avi Kapoor - Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying

The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. FTC Solar The Trade: FTC Solar, Inc. (NASDAQ: FTCI) Director Ahmad R Chatila acquired a total of 92,600 shares an average price of $0.55. To acquire these shares, it cost around $50,930. What’s Happening: On March 13, FTC ...

Related tickers: OCUP, DSGN, FTCI.

Read Full Article

Trending Tickers

Please sign in to view